Product
SOX/XELOX
3 clinical trials
5 indications
Indication
Stomach CancerIndication
Gastric CarcinomaIndication
HER2 NegativeIndication
efficacyIndication
SafetyClinical trial
A Multicenter, Prospective Phase II Clinical Study of Tislelizumab in Combination With Chemotherapy for the Perioperative Treatment of Resectable Locally Advanced Gastric and Gastroesophageal Junction AdenocarcinomaStatus: Not yet recruiting, Estimated PCD: 2026-03-31
Clinical trial
The Impact of Multimodal Rehabilitation on the Outcomes of Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy: A Phase II, Multicenter, Open Label, and Randomized Clinical StudyStatus: Not yet recruiting, Estimated PCD: 2025-05-01
Clinical trial
Clinical Efficacy and Safety of Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Resectable Gastric CancerStatus: Recruiting, Estimated PCD: 2025-04-30